Get started
Author

Kenji Fujimoto

Observed name: Fujimoto, Kenji
ORCID: 0009-0009-3181-0480
Observed ORCID: 0009-0009-3181-0480
OpenAlex ID: A5133396508
Long-term administration of the mutant IDH inhibitor DS-1001b suppresses the growth of IDH1-mutant glioma in vitro and in mouse xenograft models and alters epigenetic profiles
2026 · Kenji Fujimoto, Mai Honda-Kitahara, et al. · Acta Neuropathologica · 1
Rural medical disparities in multimodal glioblastoma treatment
2026 · Yasutomo Momii, Nobuhiro Hata, et al. · Scientific Reports
PDF
Histological grade 2 and non-contrast-enhancing phenotype provide prognostic information complementary to DNA methylation classification in TERTp-mutant molecular glioblastomas
2026 · Hiroyuki Sueyoshi, Kenji Fujimoto, et al. · Acta Neuropathologica Communications
Histological grade 2 and non-contrast-enhancing phenotype provide prognostic information complementary to DNA methylation classification in TERTp-mutant molecular glioblastomas
2026 · Sueyoshi, Hiroyuki, Fujimoto, Kenji, et al. · Figshare
Additional file 3 of Histological grade 2 and non-contrast-enhancing phenotype provide prognostic information complementary to DNA methylation classification in TERTp-mutant molecular glioblastomas
2026 · Sueyoshi, Hiroyuki, Fujimoto, Kenji, et al. · Figshare
Additional file 1 of Histological grade 2 and non-contrast-enhancing phenotype provide prognostic information complementary to DNA methylation classification in TERTp-mutant molecular glioblastomas
2026 · Sueyoshi, Hiroyuki, Fujimoto, Kenji, et al. · Figshare
Additional file 2 of Histological grade 2 and non-contrast-enhancing phenotype provide prognostic information complementary to DNA methylation classification in TERTp-mutant molecular glioblastomas
2026 · Sueyoshi, Hiroyuki, Fujimoto, Kenji, et al. · Figshare
Works count: 7
Citation count: 1
H-index: 1
I10-index:
Year
Topic
Type